HCW Biologics jumps 309% as traders react to licensing-driven Q1 profit and revenue surge

By: Quiver PriceTracker

Posted: 1 week ago / May 15, 2026 2:52 p.m. UTC

HCWB

HCW Biologics, Inc. (HCWB) is up 309.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to the company’s May 14, 2026 quarterly filing, which showed a sharp revenue jump and a return to profitability driven largely by licensing revenue recognition. Given the stock’s micro-cap profile, the magnitude of the gain also suggests momentum trading and a potential low-float squeeze layered on top of the fundamental headline.

Details:

HCW Biologics reported revenue of $6,543,001 for the three months ended March 31, 2026, versus $5,065 in the prior-year quarter.

The filing showed net income of $3,472,480 for the quarter ended March 31, 2026, compared with a net loss of $2,196,875 in the prior-year period.

Management discussion in the filing linked the quarter’s revenue spike to recognition of a nonrefundable upfront license fee from a transaction that closed on March 16, 2026, paid via a mix of cash and an in-kind equity interest in the licensee.

The filing also noted the Wugen license had been suspended for one year ending May 29, 2026, with revenue during suspension limited to ancillary activities such as storage.

Sources:

SEC, HCW Biologics Investor Relations, MarketBeat

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive HCWB Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$HCWB Hedge Fund Activity

We have seen 12 institutional investors add shares of $HCWB stock to their portfolio, and 3 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ARMISTICE CAPITAL, LLC added 300,180 shares (+inf%) to their portfolio in Q4 2025, for an estimated $291,354
HRT FINANCIAL LP added 266,393 shares (+inf%) to their portfolio in Q1 2026, for an estimated $95,901
VIRTU FINANCIAL LLC added 47,809 shares (+inf%) to their portfolio in Q1 2026, for an estimated $17,211
DRW SECURITIES, LLC removed 35,281 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $12,701
CITADEL ADVISORS LLC added 22,158 shares (+inf%) to their portfolio in Q4 2025, for an estimated $21,506
SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 20,071 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $7,225
JANE STREET GROUP, LLC added 14,134 shares (+inf%) to their portfolio in Q1 2026, for an estimated $5,088

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.